Cdr1p, a multidrug transporter from a pathogenic yeast Candida albicans, confers resistance to several unrelated drugs including anti-Candida drugs. We demonstrate that Cdr1p can specifically transport human steroid hormones namely Lestradiol and corticosterone. Saccharomyces cerevisiae transformant S-12, harbouring the CDR1 gene, accumulated about 3-fold less [
Introduction
Multidrug resistance (MDR), where cells exhibit simultaneous resistance to multiple chemically unrelated chemotherapeutic agents, has been one of the principal causes of failure of chemotherapy [1^3] . The elucidation of the mechanism by which cells develop resistance to toxic e¡ects of potent chemotherapeutic agents has revealed a great deal about the process of drug uptake, metabolism and extrusion. Overexpression of a 170 kDa glycoprotein (Pglycoprotein) was shown to be responsible for this phenomenon in mammals including humans [1^3] . Such MDR proteins are widely distributed throughout the evolutionary scale [4^6] . Yeast is no exception, in fact more than two dozen loci responsible for pleiotropic drug resistance (PDR) have been identi¢ed mostly in Saccharomyces cerevisiae and a few in Schizosaccharomyces pombe [7, 8] . The class of trans-porters in yeasts not only includes ATP binding cassette (ABC) family of transporters and multidrug resistance-associated protein family (MRP) of transporters but also a family of membrane facilitators (MFS), which are basically symporters [9] . In addition, regulatory networks of PDR, genes backed by transcription regulators, are also very well characterised [7, 9] .
The studies involving MDR in yeast have attracted much attention, since some of the species are also pathogenic to humans. Candida albicans is a dimorphic, opportunistic human pathogen, which is naturally more resistant to several drugs than S. cerevisiae [6] . In recent years, the incidence of C. albicans cells acquiring resistance to azoles and polyenes has increased considerably [6, 10, 11] . In this regard, the cloning and sequencing of a multidrug transporter, CDR1 (Candida drug resistance) in C. albicans, which is a homologue of S. cerevisiae multidrug e¥ux pump PDR5 [7, 9] , was an important step towards an understanding of the mechanism of drug resistance [12] . A few more homologues of CDR1 have been identi¢ed recently in C. albicans [13, 14] and few genes speci¢c to £uconazole and benomyl resistance have also been characterised [6, 8, 15, 16] . The knowledge of physiological substrates and role of MDRs continue to be elusive. Except for human MDR1, which is a general phospholipid translocator and steroid transporter [17, 18] and MDR2, which is a speci¢c phosphatidylcholine translocator, between lipid monolayers [19] , none of the characterised genes is so distinctly identi¢ed with its functions. Yeast MDRs are no exception and from host of genes identi¢ed as putative e¥ux pumps, none could be related with their physiological roles, the only exception being STE6, of S. cerevisiae [7, 9] . STE6 codes for an ABC protein and is known to export mating factor in yeast [20] . The fact that S. cerevisiae having disrupted SNQ2 and PDR5, shows higher accumulation of estradiol as compared to their parental strain, suggests that steroids could be physiological substrates for these ABC pumps [21, 22] .
Though Cdr1p is a homologue of PDR5p and SNQ2p, it has di¡erent pro¢le of drug resistance and regulation of its activity. PDR1 and PDR3, which are well known transcription factors which regulate PDR5 expression, do not have homologous binding domains in CDR1 promoter [9, 12] . In addition, CDR1 promoter has regulatory elements which are not found in PDR5 promoter. In view of above facts and considering the sites of infection of C. albicans in humans, it was most appropriate to ascertain if this pathogenic yeast has also adapted to transport steroids. This communication, for the ¢rst time, describes in detail the speci¢city of an energy dependent steroid transport, mediated by Cdr1p, in a background where seven ABC transporters are deleted. We also demonstrate that drugs, which are e¥uxed out by Cdr1p, competitively inhibit steroid accumulation.
Materials and methods

Strains and growth media
S. cerevisiae JG436 (Mat a, PDR5: :Tn5, leu2, met5, ura3-52, mak71, KRB1) [12] was a kind gift from Dr. J. Golin, Catholic University of America, Washington, DC, USA. S. cerevisiae AD 1234568 (Mat K, pdr1-3, his, ura3, pdr5v, snq2v, pdr10v, pdr11v, pdr15v, yor1v, ycf1v), was a kind gift from A. Go¡eau and A. Decottignies, Universite è Catholique de Louvain, Belgium. Both the strains were transformed with the CDR1 gene by a method described earlier [12] and the resulting transformants harbouring CDR1 were designated S-12 and AD-CDR1.
Transport of [ Q H]L-estradiol and corticosterone
The accumulation of steroid hormone [ Q H]L-estradiol and [
Q H]corticosterone was determined by the modi¢ed method described elsewhere [21] . The results presented show net accumulation of steroids at the indicated time and not the e¥ux. S. cerevisiae strain JG436, hypersensitive to cycloheximide due to disrupted PDR5, was used as a host to express CDR1 of C. albicans. The resulting strain S-12, hyper-resistant to cycloheximide and other drugs [12] , was used to check whether Cdr1p could transport human steroid hormones. It is pertinent to mention here that steroids, which are small hydrophobic molecules, enter S. cerevisiae cells by di¡u-sion [21] . The strain JG436 showed steady accumulation of [
Q H]L-estradiol (Fig. 1a) . However, due to continuous e¥ux of these substrates mediated by Cdr1p, strain S-12 showed much less accumulation (at 60 min JG436 had 19 pmoles/mg dry weight of [ Q H]L-estradiol while it was 7.0 pmoles/mg dry weight in S-12) (Fig. 1a and b) . Similarly, [ Q H]corticosterone was rapidly e¥uxed out from S-12 cells (at 60 min JG436 had 6.5 pmoles of [ Q H]corticosterone, while it was 3 pmoles per mg dry weight in S-12 cells) ( Fig. 2a and b) .
Although JG436 does not have a functional Pdr5, it is known to harbour several other putative e¥ux pumps, which might still mask the function of Cdr1p [23] . We therefore used a S. cerevisiae strain AD1234568 (called as AD hereafter in this paper) constructed by A. Decottignies, in A. Go¡eau's group, where in seven ABC transporter genes, e.g. PDR5, PDR10, PDR11, PDR15, SNQ2 (Saccharomyces nitroquinoline oxide resistance gene), YCF1 (yeast cadmium factor gene) and YOR1 (yeast oligomycin resistance gene) were disrupted. So all the following transport experiments have been done with strain AD harbouring CDR1 called as AD-CDR1.
Interestingly, when transport of [
Q H]L-estradiol and [ Q H]corticosterone was studied in AD-CDR1, the results were more dramatic. As can be seen from Fig.  1c and d , the AD strain showed higher accumulation of [
Q H]L-estradiol (50 pmoles/mg dry weight), the uptake could never reach above 20 pmoles/mg dry weight in AD-CDR1 and at 60 min it was less than 10 pmoles/mg dry weight. Similar was the case with [ Q H]corticosterone, where the accumulation was much less in AD-CDR1 (Fig. 2c and d) . It is important to point out here that none of these transformants was able to show the e¥ux of [
Q H]progesterone, suggesting that progesterone may not be a substrate of Cdr1p (data not shown). Although both S-12 and AD-CDR1 showed reduced accumulation as compared to their host lacking CDR1 gene, the di¡erence in accumulation levels was very signi¢cant in AD-CDR1. The deletion of seven ABC type transporters in AD-CDR1 ensured unmasked functioning of Cdr1p. A range of [
Q H]estradiol concentrations (0.1 to 10 nM) was used to determine the K m of estradiol accumulation. Total accumulation of estradiol was measured at each concentration up to 1 h. The resulting accumulation was plotted (Linweaver-Burk plot), to obtain K m values, using Sigma plot (Jandel Scienti¢c),. However, the K m values, which were in the range of 0.5^1.0 nM (data not shown), do not directly re£ect the a¤nity of estradiol.
L-estradiol and corticosterone transport mediated by Cdr1p is speci¢c
Cdr1p is known to e¥ux many unrelated hydrophobic xenobiotics and as a result it is able to confer resistance to a variety of drugs [12] . The transport of steroid hormones by Cdr1p provided an opportunity to check in vivo speci¢city of this pump. AD-CDR1 cells were exposed to a 100-fold higher concentration of other steroid hormones (200 nM) before assaying for [
Q H]L-estradiol accumulation. An excess concentration (100-fold) of L-estradiol, corticosterone, dexamethasone, cholesterol and ergosterol prevented ef£ux of labeled substrate and led to increased accumulation (Fig. 3a) . Progesterone, on the other hand, had no e¡ect on the transport of either of the steroids. Several drugs, e.g. cycloheximide, o-phenanthroline, chloramphenicol, £uconazole and rhodamine 123, which are expected to be e¥uxed by Cdr1p were also able to a¡ect the exit of both the hormones (Fig. 3a) . The transport of corticosterone also showed similar speci¢cities (data not shown).
Transport of L-estradiol and corticosterone is energy dependent
Cdr1p has been shown to contain adenosine triphosphatase (ATPase) and uridine triphosphatase (UTPase) activities, which have features very distinct from plasma membrane ATPase (PM-ATPase), e.g. broad substrate speci¢cities and pH optima (Krishnamurthy et al., unpublished results). The external pH did not signi¢cantly a¡ect the ability to transport these hormones, which correlates well with the broader pH optimum of nucleotide triphosphatase activity of Cdr1p (data not shown). The e¥ux of L-estradiol was inhibited by sodium azide as well as by other inhibitor of energy metabolism, carbonyl cyanide m-chlorophenylhydrazone (CCCP). Other inhibitors such as sodium orthovanadate (ATPase inhibitor), potassium cyanide (KCN) and valinomycin (ionophore) also prevented the exit of L-estradiol (Fig. 3b) , albeit to a lesser extent. Transport of corticosterone showed similar results indicating that it is also energy dependent (data not shown).
In conclusion, our results demonstrate that Cdr1p, a multidrug transporter, can selectively mediate energy dependent transport of human steroid hormones with high a¤nity and speci¢city. It is possible that these hormones might be physiological substrates of Cdr1p. In this regard, it is pertinent to mention that corticosteroid and estrogen binding proteins in C. albicans and other species of Candida have been identi¢ed and related to its pathogenicity [24] . The interaction of some of the azoles such as ketoconazole, with the corticosteroid receptor and binding protein has been suggested [25] . Moreover, the presence of a steroid response element in the promoter of CDR1 (unpublished results) and the upregulation of CDR1 transcription by L-estradiol, strongly suggest a possibility of a steroid receptor cascade, linked to multidrug resistance in C. albicans (Krishnamurthy et al., submitted for publication).
The steroid e¥ux system mediated by Cdr1p, could also be a part of the total sterol homeostasis of Candida cells. Studies are underway in our laboratory to con¢rm the above hypothesis.
